quinazolines has been researched along with gsk 1070916 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, N; Bhattacharyya, A; Chhajer, R; Das, N; Didwania, N; Palit, P; Shadab, M; Vaidya, T | 1 |
| Barik, MR; Borah, NA; Jha, A; Kaliki, S; Mittal, R; Patnaik, S; Raghav, SK; Rath, S; Reddy, MM; Sradhanjali, S; Tripathy, D | 1 |
2 other study(ies) available for quinazolines and gsk 1070916
| Article | Year |
|---|---|
Leishmania donovani Aurora kinase: A promising therapeutic target against visceral leishmaniasis.
Topics: Adenosine Triphosphate; Amino Acid Sequence; Animals; Aurora Kinases; Aza Compounds; Catalytic Domain; Cell Cycle; Cell Survival; Cytokinesis; Female; Indoles; Kinetics; Leishmania donovani; Leishmaniasis, Visceral; Mice; Mice, Inbred BALB C; Molecular Docking Simulation; Organophosphates; Protein Kinase Inhibitors; Quinazolines; Sulfonamides | 2016 |
Aurora Kinase B Expression, Its Regulation and Therapeutic Targeting in Human Retinoblastoma.
Topics: Apoptosis; Aurora Kinase B; Aza Compounds; Benzamides; Cell Cycle; Cell Survival; Gene Expression Regulation, Enzymologic; Gene Knockdown Techniques; Humans; Immunoblotting; Immunohistochemistry; Indoles; Molecular Targeted Therapy; Organophosphates; Protein Kinase Inhibitors; Quinazolines; Real-Time Polymerase Chain Reaction; Retinal Neoplasms; Retinoblastoma; RNA, Messenger; Tumor Cells, Cultured | 2021 |